DYER TIMOTHY MARK enters ADDEX THERAPEUTICS LTD. with 16.85M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001104659-26-030243
DirectorOfficer10% Owner· Chief Executive Officer
Since Mar 2026
16.85M
Baseline shares
100% direct
16.85M
Direct ownership
1 position
3.37M
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common stock
DirectShares owned16.85M
Total
16.85M direct16.85M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common stock | 16.85M | Direct |
| Total | 16.85M | 16.85M direct |
Derivative Holdings1
Stock-Option (Right to Buy)
DirectUnderlying security
Common stock
Underlying shares
3.37M
Shares owned
N/A
Exercise price
0.064
Expiration
—
Exercise window
—
Total
Underlying
3.37M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock-Option (Right to Buy) Direct | Common stock | 0.064 | — | — | 3.37M | N/A |
| Total | 3.37M | 0.00 | ||||